Abstract
Background Intrauterine Growth Restriction (IUGR) may contribute to the risk of Arterial Hypertension (AH) in adulthood, but its impact after the 3rd decade of life, where environmental factors are prevalent, is still uncertain.
Methods 1,594 individuals with 38 and 39 years-old were evaluated from an original cohort of 6,824 newborns between 1978 and 1979. Biochemical tests, office BP, and anthropometric measurements were done. Also, questionnaires regarding data on income, habits, education, and information about birth were recorded. Krammer’s criteria defined IURG. Subclinical vascular damage was investigated using Pulse Wave Velocity (PWV).
Results The IURG group has higher BP [Systolic BP: 123.3±15.6 vs. 121.2± 13.4 (p=0.049); Diastolic BP: 79.1 ± 10.6 mmHg vs. 76.8 ± 9.9 mmHg (p=0.002)] and higher prevalence of HA [56 vs. 49%; OR=1.30 (1.1-1.8), p=0.04] than the control group. There were no differences in PWV and prevalence of early vascular aging (PWV > 2SD of the mean of normal age value) between groups.
Conclusion IURG was associated with an increase in BP and with a higher risk of hypertension at the end of the third decade of life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
CNPQ grant number 422504/2016-5 The authors, at no time, received payment or services from third parties for any aspect of the submitted work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The volunteers were evaluated and interviewed by a trained group at the Clinical Research Centre of the Teaching Hospital of the School of Medicine of Ribeirao Preto, University of São Paulo. Standardized questionnaires regarding socioeconomic status were applied. All the participants signed a free informed consent form. The study was approved by the institutional review board (protocol 1.282.710) following the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
We declare that the data mentioned in the manuscript is open for consultation.
